1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chi, S.-W.
Park, K.-H.
Suk, J.-E.
Olivera, B.M.
McIntosh, J.M.
Han, K.-H.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C5 H9 N O3
131.130
n
4-HYDROXYPROLINE
HYDROXYPROLINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
H2 N
16.023
AMINO GROUP
non-polymer
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
278
42208
42213
10.1074/jbc.M303342200
12900418
Solution Conformation of alphaA-conotoxin EIVA, a Potent Neuromuscular Nicotinic Acetylcholine Receptor Antagonist from Conus ermineus
2003
10.2210/pdb1pqr/pdb
pdb_00001pqr
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
3105.495
Alpha-A-conotoxin EIVA
1
syn
polymer
no
yes
GCCGPY(HYP)NAACH(HYP)CGCKVGR(HYP)(HYP)YCDR(HYP)SGG(NH2)
GCCGPYPNAACHPCGCKVGRPPYCDRPSGGX
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
struct_site
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-11-04
1
1
2008-04-29
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
_struct_site.pdbx_auth_asym_id
_struct_site.pdbx_auth_comp_id
_struct_site.pdbx_auth_seq_id
RCSB
Y
PDBJ
2003-06-18
REL
REL
This sequence occurs naturally in Conus ermineus venom.
sample
This structure was determined using standard 2D homonuclear techniques.
back calculated data agree with experimental NOESY spectrum
50
18
2D NOESY
2D TOCSY
DQF-COSY
PE-COSY
0.01
3.6
1
atm
288
K
The structures are based on a total of 388 NOE-derived distance constraints, 11 dihedral angle restraints
distance geometry, molecular dynamics
5
closest to the average
5mM alpha-A-conotoxin EIVA
90% H2O/10% D2O
collection
VNMR
6.1B
processing
Felix
98.0
refinement
Discover
2.98
600
Varian
INOVA
GLY
1
n
1
GLY
1
A
CYS
2
n
2
CYS
2
A
CYS
3
n
3
CYS
3
A
GLY
4
n
4
GLY
4
A
PRO
5
n
5
PRO
5
A
TYR
6
n
6
TYR
6
A
HYP
7
n
7
HYP
7
A
ASN
8
n
8
ASN
8
A
ALA
9
n
9
ALA
9
A
ALA
10
n
10
ALA
10
A
CYS
11
n
11
CYS
11
A
HIS
12
n
12
HIS
12
A
HYP
13
n
13
HYP
13
A
CYS
14
n
14
CYS
14
A
GLY
15
n
15
GLY
15
A
CYS
16
n
16
CYS
16
A
LYS
17
n
17
LYS
17
A
VAL
18
n
18
VAL
18
A
GLY
19
n
19
GLY
19
A
ARG
20
n
20
ARG
20
A
HYP
21
n
21
HYP
21
A
HYP
22
n
22
HYP
22
A
TYR
23
n
23
TYR
23
A
CYS
24
n
24
CYS
24
A
ASP
25
n
25
ASP
25
A
ARG
26
n
26
ARG
26
A
HYP
27
n
27
HYP
27
A
SER
28
n
28
SER
28
A
GLY
29
n
29
GLY
29
A
GLY
30
n
30
GLY
30
A
NH2
31
n
31
NH2
31
A
author_defined_assembly
1
monomeric
A
HYP
7
4-HYDROXYPROLINE
A
HYP
7
PRO
A
HYP
13
4-HYDROXYPROLINE
A
HYP
13
PRO
A
HYP
21
4-HYDROXYPROLINE
A
HYP
21
PRO
A
HYP
22
4-HYDROXYPROLINE
A
HYP
22
PRO
A
HYP
27
4-HYDROXYPROLINE
A
HYP
27
PRO
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
3
A
A
O
HB3
HYP
ARG
22
26
1.27
6
A
A
SG
HG3
CYS
ARG
14
20
1.45
7
A
A
O
HB3
HYP
ARG
22
26
1.42
8
A
A
O
HB3
HYP
ARG
22
26
1.48
13
A
A
HB3
HD22
ARG
HYP
26
27
1.26
16
A
A
HB3
HD22
ARG
HYP
20
21
1.20
16
A
A
HB3
HD23
ARG
HYP
26
27
1.32
17
A
A
HB3
HD23
ARG
HYP
26
27
0.95
1
8.71
1.20
111.50
120.21
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
1
8.03
1.30
111.50
119.53
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
1
3.68
0.50
120.30
123.98
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
1
-6.14
0.90
118.30
112.16
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
1
3.74
0.50
120.30
124.04
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
2
8.14
1.20
111.50
119.64
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
2
7.96
1.30
111.50
119.46
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
2
3.73
0.50
120.30
124.03
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
2
-5.96
0.90
118.30
112.34
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
2
3.70
0.50
120.30
124.00
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
3
7.40
1.20
111.50
118.90
A
A
A
CB
CA
C
CYS
CYS
CYS
11
11
11
N
3
7.86
1.30
111.50
119.36
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
3
3.68
0.50
120.30
123.98
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
3
6.13
0.90
118.30
124.43
A
A
A
CB
CG
OD1
ASP
ASP
ASP
25
25
25
N
3
-6.82
0.90
118.30
111.48
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
3
3.70
0.50
120.30
124.00
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
4
7.56
1.20
111.50
119.06
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
4
8.73
1.20
111.50
120.23
A
A
A
CB
CA
C
CYS
CYS
CYS
11
11
11
N
4
8.10
1.30
111.50
119.60
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
4
4.05
0.50
120.30
124.35
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
4
-5.94
0.90
118.30
112.36
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
4
3.72
0.50
120.30
124.02
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
5
8.08
1.30
111.50
119.58
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
5
3.64
0.50
120.30
123.94
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
5
-6.07
0.90
118.30
112.23
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
5
3.61
0.50
120.30
123.91
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
6
8.48
1.20
111.50
119.98
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
6
7.96
1.30
111.50
119.46
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
6
3.67
0.50
120.30
123.97
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
6
-6.09
0.90
118.30
112.21
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
6
3.65
0.50
120.30
123.95
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
7
7.60
1.20
111.50
119.10
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
7
8.00
1.30
111.50
119.50
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
7
3.78
0.50
120.30
124.08
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
7
-6.00
0.90
118.30
112.30
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
7
3.75
0.50
120.30
124.05
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
8
8.07
1.30
111.50
119.57
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
8
3.88
0.50
120.30
124.18
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
8
-6.15
0.90
118.30
112.15
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
8
3.73
0.50
120.30
124.03
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
9
8.07
1.30
111.50
119.57
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
9
3.72
0.50
120.30
124.02
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
9
-6.03
0.90
118.30
112.27
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
9
3.66
0.50
120.30
123.96
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
10
7.98
1.30
111.50
119.48
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
10
3.89
0.50
120.30
124.19
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
10
-6.07
0.90
118.30
112.23
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
10
3.70
0.50
120.30
124.00
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
11
8.02
1.30
111.50
119.52
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
11
3.86
0.50
120.30
124.16
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
11
-6.12
0.90
118.30
112.18
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
11
3.71
0.50
120.30
124.01
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
12
8.04
1.30
111.50
119.54
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
12
3.57
0.50
120.30
123.87
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
12
-5.66
0.90
118.30
112.64
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
12
3.65
0.50
120.30
123.95
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
13
8.05
1.20
111.50
119.55
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
13
7.96
1.30
111.50
119.46
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
13
3.78
0.50
120.30
124.08
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
13
-6.00
0.90
118.30
112.30
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
13
3.69
0.50
120.30
123.99
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
14
8.06
1.30
111.50
119.56
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
14
3.81
0.50
120.30
124.11
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
14
-6.06
0.90
118.30
112.24
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
14
3.73
0.50
120.30
124.03
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
15
8.15
1.20
111.50
119.65
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
15
7.99
1.30
111.50
119.49
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
15
3.79
0.50
120.30
124.09
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
15
-5.80
0.90
118.30
112.50
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
15
3.72
0.50
120.30
124.02
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
16
7.94
1.30
111.50
119.44
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
16
-12.07
2.00
110.40
98.33
A
A
A
CB
CA
C
ARG
ARG
ARG
20
20
20
N
16
3.70
0.50
120.30
124.00
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
16
-6.01
0.90
118.30
112.29
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
16
3.71
0.50
120.30
124.01
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
17
8.36
1.20
111.50
119.86
A
A
A
CB
CA
C
CYS
CYS
CYS
2
2
2
N
17
7.97
1.30
111.50
119.47
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
17
3.71
0.50
120.30
124.01
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
17
-5.96
0.90
118.30
112.34
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
17
3.66
0.50
120.30
123.96
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
18
8.00
1.30
111.50
119.50
A
A
A
ND1
CE1
NE2
HIS
HIS
HIS
12
12
12
N
18
3.81
0.50
120.30
124.11
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
20
20
20
N
18
-5.87
0.90
118.30
112.43
A
A
A
CB
CG
OD2
ASP
ASP
ASP
25
25
25
N
18
3.62
0.50
120.30
123.92
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
26
26
26
N
1
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
2
A
A
CG
CD2
HIS
HIS
12
12
0.056
0.009
1.354
1.410
N
3
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
4
A
A
CG
CD2
HIS
HIS
12
12
0.059
0.009
1.354
1.413
N
5
A
A
CG
CD2
HIS
HIS
12
12
0.056
0.009
1.354
1.410
N
6
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
7
A
A
CG
CD2
HIS
HIS
12
12
0.054
0.009
1.354
1.408
N
8
A
A
CG
CD2
HIS
HIS
12
12
0.064
0.009
1.354
1.418
N
9
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
10
A
A
CG
CD2
HIS
HIS
12
12
0.056
0.009
1.354
1.410
N
12
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
13
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
14
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
15
A
A
CG
CD2
HIS
HIS
12
12
0.055
0.009
1.354
1.409
N
1
A
CYS
2
-124.15
-121.34
1
A
CYS
3
-150.77
-86.86
1
A
HYP
7
37.25
-174.70
1
A
ASN
8
-143.11
39.09
1
A
ALA
9
-90.36
-92.00
1
A
CYS
14
-116.87
56.07
1
A
LYS
17
-80.53
-76.90
1
A
HYP
21
-41.77
159.01
1
A
HYP
27
-57.67
107.80
2
A
CYS
2
-119.32
-123.04
2
A
CYS
3
-150.75
-79.81
2
A
HYP
7
20.76
-144.64
2
A
ASN
8
-133.51
-52.15
2
A
ALA
9
-71.33
-84.18
2
A
LYS
17
-80.43
-71.21
2
A
HYP
21
-48.45
163.60
2
A
HYP
27
-50.53
107.77
3
A
CYS
3
-133.29
-85.91
3
A
ASN
8
-101.19
-76.07
3
A
ALA
9
-90.56
-110.00
3
A
CYS
11
57.82
82.34
3
A
HYP
27
-47.09
102.16
3
A
SER
28
-150.68
-83.55
4
A
CYS
2
-99.19
-98.61
4
A
CYS
3
-139.88
-108.61
4
A
ASN
8
-85.99
-82.48
4
A
ALA
9
-90.22
-92.03
4
A
LYS
17
-85.52
-72.95
4
A
HYP
27
-46.87
105.71
5
A
CYS
2
-87.14
-107.99
5
A
CYS
3
-150.74
-76.87
5
A
ASN
8
-141.40
-111.10
5
A
ALA
10
-111.79
71.98
5
A
CYS
14
-116.63
74.20
5
A
HYP
21
-38.84
160.64
5
A
HYP
27
-57.80
102.84
6
A
CYS
2
-124.39
-121.36
6
A
CYS
3
-150.82
-80.83
6
A
ASN
8
-152.99
-83.95
6
A
ALA
9
-90.75
-93.72
6
A
ALA
10
-107.41
54.19
6
A
CYS
14
-114.56
54.86
6
A
LYS
17
-79.80
-72.19
6
A
HYP
21
-45.50
157.99
6
A
HYP
27
-52.36
109.18
7
A
CYS
2
-98.59
-110.39
7
A
CYS
3
-150.45
-75.26
7
A
ASN
8
-140.54
-82.14
7
A
ALA
9
-90.71
-95.45
7
A
CYS
14
-92.13
30.14
7
A
ASP
25
-132.45
-38.44
7
A
HYP
27
-53.03
103.18
8
A
CYS
2
-81.54
-87.04
8
A
CYS
3
-144.07
-95.86
8
A
ALA
9
-90.26
40.43
8
A
ALA
10
31.33
64.37
8
A
CYS
14
-97.76
38.58
8
A
LYS
17
-116.54
-74.72
8
A
ASP
25
-134.98
-37.68
8
A
HYP
27
-53.81
103.72
9
A
CYS
2
-160.57
94.45
9
A
TYR
6
-150.38
-46.21
9
A
HYP
7
-77.85
-163.25
9
A
ASN
8
-139.61
-53.46
9
A
ALA
10
-90.73
53.36
9
A
CYS
14
-108.80
64.89
9
A
CYS
16
-90.60
-100.42
9
A
LYS
17
164.60
-82.87
9
A
HYP
21
-41.54
159.68
9
A
HYP
27
-67.86
99.41
10
A
CYS
2
-134.08
-88.99
10
A
CYS
3
-137.28
-71.44
10
A
ASN
8
-141.83
-72.60
10
A
CYS
14
-87.85
30.31
10
A
LYS
17
-108.09
-71.75
10
A
HYP
21
-45.65
160.22
11
A
CYS
3
-115.66
-80.88
11
A
ALA
9
-90.51
55.50
11
A
ALA
10
30.46
62.70
11
A
HYP
21
-39.85
154.41
11
A
HYP
27
-54.33
107.94
12
A
CYS
2
-91.37
-81.49
12
A
CYS
3
-149.21
-73.82
12
A
ASN
8
-139.14
-85.70
12
A
ALA
9
-90.73
-91.38
12
A
ALA
10
-107.74
46.00
12
A
CYS
14
-108.13
59.15
12
A
HYP
21
-44.64
156.28
12
A
HYP
27
-53.20
107.87
13
A
CYS
2
-108.22
-118.01
13
A
CYS
3
-150.68
-75.02
13
A
LYS
17
-76.55
-70.75
13
A
ARG
26
-76.31
-162.55
13
A
HYP
27
-57.58
94.01
14
A
CYS
2
-90.78
-71.36
14
A
CYS
3
-137.37
-89.73
14
A
ASN
8
-86.32
-82.94
14
A
ALA
9
-90.47
-88.73
14
A
HYP
21
-55.08
171.30
14
A
HYP
27
-58.28
102.28
15
A
CYS
2
-115.01
-121.09
15
A
CYS
3
-150.83
-77.59
15
A
TYR
6
-93.53
-75.55
15
A
HYP
7
-70.99
-162.22
15
A
ALA
9
-71.28
-83.28
15
A
LYS
17
-84.56
-72.55
15
A
HYP
21
-45.18
164.62
15
A
HYP
27
-56.16
102.69
16
A
PRO
5
-34.98
-38.27
16
A
HYP
7
-84.76
39.95
16
A
ASN
8
-172.31
-52.11
16
A
CYS
14
-89.90
35.08
16
A
HYP
21
-55.93
170.67
16
A
ARG
26
-77.53
-160.91
16
A
HYP
27
-60.49
94.84
17
A
CYS
2
-113.31
-116.77
17
A
CYS
3
-150.64
-90.25
17
A
ASN
8
-135.64
-104.80
17
A
ALA
9
-90.89
-81.07
17
A
CYS
14
-114.76
64.45
17
A
HYP
21
-42.58
159.78
17
A
ARG
26
-86.37
-150.20
18
A
CYS
2
-115.26
65.80
18
A
PRO
5
-38.10
-30.75
18
A
HYP
7
-87.64
34.73
18
A
ASN
8
-170.52
-53.02
18
A
ALA
10
-118.73
64.27
18
A
CYS
14
-117.67
56.01
18
A
LYS
17
-91.20
-62.67
18
A
HYP
21
-45.38
164.33
18
A
HYP
27
-51.94
107.40
Solution Conformation of alphaA-Conotoxin EIVA
1
N
N
A
HYP
21
A
HYP
21
HELX_P
A
ARG
26
A
ARG
26
1
1
6
disulf
1.992
A
CYS
2
A
SG
CYS
2
1_555
A
CYS
16
A
SG
CYS
16
1_555
disulf
2.001
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
1.982
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
24
A
SG
CYS
24
1_555
covale
1.372
both
A
TYR
6
A
C
TYR
6
1_555
A
HYP
7
A
N
HYP
7
1_555
covale
1.353
both
A
HYP
7
A
C
HYP
7
1_555
A
ASN
8
A
N
ASN
8
1_555
covale
1.373
both
A
HIS
12
A
C
HIS
12
1_555
A
HYP
13
A
N
HYP
13
1_555
covale
1.352
both
A
HYP
13
A
C
HYP
13
1_555
A
CYS
14
A
N
CYS
14
1_555
covale
1.369
both
A
ARG
20
A
C
ARG
20
1_555
A
HYP
21
A
N
HYP
21
1_555
covale
1.373
both
A
HYP
21
A
C
HYP
21
1_555
A
HYP
22
A
N
HYP
22
1_555
covale
1.345
both
A
HYP
22
A
C
HYP
22
1_555
A
TYR
23
A
N
TYR
23
1_555
covale
1.370
both
A
ARG
26
A
C
ARG
26
1_555
A
HYP
27
A
N
HYP
27
1_555
covale
1.346
both
A
HYP
27
A
C
HYP
27
1_555
A
SER
28
A
N
SER
28
1_555
covale
1.325
both
A
GLY
30
A
C
GLY
30
1_555
A
NH2
31
A
N
NH2
31
1_555
TOXIN
Alpha-HELIX, TWO DISULFIDE BONDS, C-TERM AMIDATION, TOXIN
A
GLY
1
A
GLY
1
14
A
CYS
2
A
CYS
2
5.50
CXVA_CONER
UNP
1
1
P58782
GCCGPYPNAACHPCGCKVGRPPYCDRPSGG
1
30
1PQR
1
30
P58782
A
1
1
30
1
PRO
modified residue
HYP
7
1PQR
A
P58782
UNP
7
7
1
PRO
modified residue
HYP
13
1PQR
A
P58782
UNP
13
13
1
PRO
modified residue
HYP
21
1PQR
A
P58782
UNP
21
21
1
PRO
modified residue
HYP
22
1PQR
A
P58782
UNP
22
22
1
PRO
modified residue
HYP
27
1PQR
A
P58782
UNP
27
27
BINDING SITE FOR RESIDUE NH2 A 31
A
NH2
31
Software
1
A
GLY
30
A
GLY
30
1
1_555